CAIDYA
LIVE

Serial Number

97533863

Owner

Clinipace, Inc.

Attorney

Margarita Wallach, Esq.

First Use Date

Oct 3, 2022

Filing Date

Aug 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CAIDYA Trademark

Serial Number: 97533863 • Registration: 7517007

CAIDYA is a trademark filed by Clinipace, Inc. on August 3, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clinipace, Inc. (14 trademarks)

Suite 100
Morrisville, NC 27560

Entity Type: 03

Trademark Details

Filing Date

August 3, 2022

Registration Date

September 24, 2024

First Use Anywhere

October 3, 2022

First Use in Commerce

October 3, 2022

Published for Opposition

October 17, 2023

Goods & Services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields

Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; Software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials; Contract research organization (CRO) services, namely, custom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 17, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 17, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 1, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 1, 2024 AITU
USE AMENDMENT FILED
Jun 12, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 12, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 7, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 7, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 7, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2023 CNRT
ASSIGNED TO EXAMINER
May 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2022 NWOS
NEW APPLICATION ENTERED
Aug 6, 2022 NWAP